BIOCEPT, INC. Deferred Tax Assets, in Process Research and Development
BIOCEPT, INC. had Deferred Tax Assets, in Process Research and Development of $1.03 million as of 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2023-04-17
- 2022-12-31: Deferred Tax Assets, in Process Research and Development $1.03M.
- 2021-12-31: Deferred Tax Assets, in Process Research and Development $1.03M.
- 2020-12-31: Deferred Tax Assets, in Process Research and Development $3.69M; Deferred Tax Assets, in Process Research and Development as first filed $3.69M.
- 2019-12-31: Deferred Tax Assets, in Process Research and Development $3.32M.
| Period end | Deferred Tax Assets, in Process Research and Development | Deferred Tax Assets, in Process Research and Development as first filed |
|---|---|---|
| 2022-12-31 | $1.03M 10-K · filed 2023-04-17 | |
| 2021-12-31 | $1.03M 10-K · filed 2023-04-17 | |
| 2020-12-31 | $3.69M 10-K · filed 2022-04-05 | $3.69M 10-K · filed 2021-03-31 |
| 2019-12-31 | $3.32M 10-K · filed 2021-03-31 | |
| 2018-12-31 | $2.96M 10-K · filed 2020-03-27 | |
| 2017-12-31 | $2.69M 10-K · filed 2019-03-29 | $2.69M 10-K · filed 2018-03-28 |
| 2016-12-31 | $2.24M 10-K · filed 2018-03-28 | |
| 2015-12-31 | $2.24M 10-K · filed 2017-03-28 | |
| 2014-12-31 | $5.24M 10-K · filed 2016-03-10 | |
| 2013-12-31 | $5.11M 10-K · filed 2015-03-11 |